Regeneron Pharma (REGN) Price Target Raised to $425 at Deutsche Bank
Deutsche Bank reiterated a Buy rating on Regeneron Pharma (NASDAQ: REGN) and raised its price target to $425.00 (from $410.00).Analyst ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)